Filing Details

Accession Number:
0001140361-21-021497
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-17 19:09:59
Reporting Period:
2021-06-15
Accepted Time:
2021-06-17 19:09:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472091 Pds Biotechnology Corp PDSB Pharmaceutical Preparations (2834) 264231384
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654337 Kamil Ali-Jackson C/O Pds Biotechnology Corporation
25B Vreeland Road
Florham Park NJ 07932
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-15 11,764 $8.50 11,764 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2021-06-17 9,000 $0.00 9,000 $9.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,000 2031-06-17 No 4 A Direct
Footnotes
  1. Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021.
  2. The Stock Option will vest in full and become fully exercisable on June 17, 2022.